NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Flowco Holdings Inc. ("Flowco" or the "Company") (NYSE:FLOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Everus Construction Group, Inc. (NYSE:ECG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/everus-construction-group-inc-lawsuit-submission-form?prid=148526&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=148534&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Krispy Kreme, Inc. ("Krispy Kreme, Inc.") (NASDAQ:DNUT) concerning possible violations of federal securities laws. Krispy Kreme issued a press release on May 8, 2025, reporting its financial results for the first quarter of 2025.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=148532&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

LiqTech International, Inc. (NASDAQ:LIQT ) Q1 2025 Earnings Conference Call May 14, 2025 9:00 AM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Fei Chen - Chief Executive Officer David Kowalczyk - Chief Financial Officer & Chief Operating Officer Conference Call Participants Operator Good day, and welcome to the LiqTech International Reports First Quarter 2025 Financial Results Call. All participants will be listen-only mode.

China Automotive Systems, Inc. (NASDAQ:CAAS ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Kevin Theiss - IR Qizhou Wu - President, CEO & Director Jie Li - CFO Conference Call Participants Gary Nash - Nashco Systems Ltd Operator Good morning, everyone, and welcome to China Automotive Systems' First Quarter 2025 Conference Call. At this time, all participants are in a listen - only mode and we will be opening the floor for questions following the presentation.

Although earnings season is winding down, there are still a few reports next week worth monitoring.

Phoenix New Media Limited (NYSE:FENG ) Q1 2025 Results Conference Call May 13, 2025 9:30 PM ET Company Participants Muzi Guo - Investor Relations Manager Yusheng Sun - Chief Executive Officer Edward Lu - Chief Financial Officer Conference Call Participants Alice Tang - First Shanghai Operator Good day, and thank you for standing by. Welcome to Phoenix New Media First Quarter 2025 Earnings Call.

Endeavour Silver's Q1 top line reflects lower ounces sold in the quarter, offset by higher average realized prices.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Perpetua To Contact Him Directly To Discuss Their Options

CNBC's Kristina Partsinevelos reports on news regarding CoreWeave.

Editas Medicine, Inc. (NASDAQ:EDIT ) BofA Securities 2025 Healthcare Conference May 14, 2025 8:15 PM ET Company Participants Amy Parison - CFO Christi Bernett - SVP of IR Conference Call Participants Alec Stranahan - BofA Securities Alec Stranahan Welcome to the last fireside for day 1 of the 2025 Bank of America Healthcare Conference. Thanks for joining this session with Editas.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Open Lending To Contact Him Directly To Discuss Their Options

LeddarTech Holdings Inc. (NASDAQ:LDTC ) Q2 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Mike Bishop - Investor Relations Frantz Saintellemy - President & Chief Executive Officer Christopher Stewart - Chief Financial Officer Conference Call Participants Operator Thank you for standing by and welcome to the LeddarTech Second Quarter 2025 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=148527&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=148522&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=148524&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your SoundHound AI, Inc. (NASDAQ:SOUN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/soundhound-ai-inc-lawsuit-submission-form?prid=148525&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ:IOVA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.